ArticleCureus2025
Severe Anorectal Mpox With Newly Diagnosed HIV and Syphilis: A Diagnostic and Management Challenge.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mpox has re-emerged globally in non-endemic regions, challenging clinicians with diverse mucocutaneous manifestations that frequently mimic other sexually transmitted infections (STIs). Early genital and anorectal lesions may resemble herpes simplex virus or syphilis, often resulting in diagnostic error and treatment delay. Lesion distribution frequently corresponds to the route of transmission, further complicating clinical recognition. We describe a 25-year-old male who presented with diffuse pustular and vesicular eruptions, including extensive anorectal and genital involvement, confirmed as Mpox by polymerase chain reaction (PCR) testing. Additional evaluation revealed previously undiagnosed HIV infection with marked immunosuppression and latent syphilis. This case underscores the diagnostic complexity and therapeutic urgency of Mpox in patients with concurrent STIs and highlights the necessity of comprehensive sexual-health screening, early antiviral initiation, and multidisciplinary management during ongoing outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.